NAMSTEYA
Dead / Abandoned — Abandoned — no statement of use filed (as of 29 Dec 2025)
What this means for you
This application is over — abandoned 29 Dec 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98388302
- Mark type
- Stylized text
- Filed
- 02 Feb 2024
- Published for opposition
- 01 Oct 2024
- Abandoned
- 29 Dec 2025
- Attorney of record
- Kristen Ruisi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in the treatment of Tourette Syndrome; Pharmaceutical preparations and substances for use in the treatment of Restless Legs Syndrome with Augmentation; Pharmaceutical preparations and substances for use in the treatment of central nervous system disorders
Owner
- Emalex Biosciences, Inc., Chicago, IL, US
- Emalex Biosciences, Inc., Chicago, IL, US
Prosecution history
- 29 Dec 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 29 Dec 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 11 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Apr 2025 — SOU EXTENSION 1 GRANTED
- 10 Apr 2025 — SOU EXTENSION 1 FILED
- 10 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Oct 2024 — PUBLISHED FOR OPPOSITION
- 11 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Aug 2024 — ASSIGNED TO EXAMINER
- 01 Mar 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 06 Feb 2024 — NEW APPLICATION ENTERED